The effect of levetiracetam on high-frequency oscillations in patients with AD and epilepsy shows its potential as a biomarker for disease detection.

Seizures were reduced by a median of 40% in the stimulated group by the end of the blinded phase... Epilepsy is a debilitating condition that can be difficult to treat effectively with current ...